CXADR and B-cell non-Hodgkin lymphoma: In addition, Ye et al. designed LNPs that contain CAR mRNA and generate anti-CD19 CAR M by transferring LNPs to murine primary macrophages, demonstrating notable cytotoxic effects against human B-cell lymphoma in-vitro [126].